vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and TELOS CORP (TLS). Click either name above to swap in a different company.
TELOS CORP is the larger business by last-quarter revenue ($46.8M vs $34.1M, roughly 1.4× Karyopharm Therapeutics Inc.). TELOS CORP runs the higher net margin — -34.9% vs -299.9%, a 265.0% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 11.6%). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs 1.4%).
Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.
KPTI vs TLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $46.8M |
| Net Profit | $-102.2M | $-16.3M |
| Gross Margin | — | 35.0% |
| Operating Margin | -52.4% | -39.6% |
| Net Margin | -299.9% | -34.9% |
| Revenue YoY | 11.6% | 77.4% |
| Net Profit YoY | -232.0% | -74.8% |
| EPS (diluted) | $-7.02 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $46.8M | ||
| Q3 25 | $44.0M | $51.4M | ||
| Q2 25 | $37.9M | $36.0M | ||
| Q1 25 | $30.0M | $30.6M | ||
| Q4 24 | $30.5M | $26.4M | ||
| Q3 24 | $38.8M | $23.8M | ||
| Q2 24 | $42.8M | $28.5M | ||
| Q1 24 | $33.1M | $29.6M |
| Q4 25 | $-102.2M | $-16.3M | ||
| Q3 25 | $-33.1M | $-2.1M | ||
| Q2 25 | $-37.3M | $-9.5M | ||
| Q1 25 | $-23.5M | $-8.6M | ||
| Q4 24 | $-30.8M | $-9.3M | ||
| Q3 24 | $-32.1M | $-28.1M | ||
| Q2 24 | $23.8M | $-7.8M | ||
| Q1 24 | $-37.4M | $-7.4M |
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | 39.9% | ||
| Q2 25 | — | 33.2% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 40.3% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 34.1% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | -52.4% | -39.6% | ||
| Q3 25 | -34.6% | -4.8% | ||
| Q2 25 | -64.3% | -27.5% | ||
| Q1 25 | -110.8% | -29.5% | ||
| Q4 24 | -102.4% | -37.6% | ||
| Q3 24 | -67.8% | -121.4% | ||
| Q2 24 | -65.7% | -30.3% | ||
| Q1 24 | -101.9% | -28.5% |
| Q4 25 | -299.9% | -34.9% | ||
| Q3 25 | -75.2% | -4.1% | ||
| Q2 25 | -98.2% | -26.5% | ||
| Q1 25 | -78.2% | -28.1% | ||
| Q4 24 | -100.8% | -35.4% | ||
| Q3 24 | -82.7% | -118.0% | ||
| Q2 24 | 55.6% | -27.2% | ||
| Q1 24 | -112.8% | -24.9% |
| Q4 25 | $-7.02 | $-0.22 | ||
| Q3 25 | $-3.82 | $-0.03 | ||
| Q2 25 | $-4.32 | $-0.13 | ||
| Q1 25 | $-2.77 | $-0.12 | ||
| Q4 24 | $-2.33 | $-0.13 | ||
| Q3 24 | $-3.85 | $-0.39 | ||
| Q2 24 | $-2.97 | $-0.11 | ||
| Q1 24 | $-4.85 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $53.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $96.0M |
| Total Assets | $108.4M | $139.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | $53.2M | ||
| Q3 25 | $37.7M | $59.0M | ||
| Q2 25 | $38.7M | $57.0M | ||
| Q1 25 | $38.8M | $57.8M | ||
| Q4 24 | $62.5M | $54.6M | ||
| Q3 24 | $72.8M | $69.8M | ||
| Q2 24 | $84.8M | $80.1M | ||
| Q1 24 | $30.6M | $93.9M |
| Q4 25 | $-292.9M | $96.0M | ||
| Q3 25 | $-269.3M | $119.7M | ||
| Q2 25 | $-238.9M | $118.4M | ||
| Q1 25 | $-205.9M | $126.1M | ||
| Q4 24 | $-186.0M | $127.1M | ||
| Q3 24 | $-159.6M | $129.5M | ||
| Q2 24 | $-132.1M | $149.1M | ||
| Q1 24 | $-169.0M | $154.4M |
| Q4 25 | $108.4M | $139.9M | ||
| Q3 25 | $96.2M | $164.3M | ||
| Q2 25 | $104.9M | $165.0M | ||
| Q1 25 | $127.7M | $158.1M | ||
| Q4 24 | $164.4M | $158.2M | ||
| Q3 24 | $189.5M | $166.3M | ||
| Q2 24 | $214.0M | $182.4M | ||
| Q1 24 | $204.5M | $195.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $8.0M |
| Free Cash FlowOCF − Capex | — | $8.0M |
| FCF MarginFCF / Revenue | — | 17.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $8.0M | ||
| Q3 25 | $-5.9M | $9.1M | ||
| Q2 25 | $-18.7M | $7.0M | ||
| Q1 25 | $-39.0M | $6.1M | ||
| Q4 24 | $-25.8M | $-10.5M | ||
| Q3 24 | $-19.5M | $-7.1M | ||
| Q2 24 | $-38.5M | $-8.0M | ||
| Q1 24 | $-43.7M | $-350.0K |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $8.7M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | $-25.9M | $-12.4M | ||
| Q3 24 | — | $-7.1M | ||
| Q2 24 | — | $-8.2M | ||
| Q1 24 | $-43.9M | $-447.0K |
| Q4 25 | — | 17.0% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | -84.7% | -47.0% | ||
| Q3 24 | — | -30.0% | ||
| Q2 24 | — | -28.9% | ||
| Q1 24 | -132.6% | -1.5% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 0.2% | 7.1% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.6% | 0.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
